TriStar Health Partners

TriStar Health Partners is a venture capital firm established in 2009 and located in Nashville, Tennessee, with an additional office in Louisville, Kentucky. The firm specializes in early-stage investments, primarily targeting healthcare innovation and life sciences. Its investment focus encompasses a range of areas including diagnostics, medical devices, healthcare information technology, and healthcare services. TriStar Health Partners is particularly interested in technologies and companies emerging from universities and research institutions, while also considering existing companies without direct ties to academia. The firm predominantly invests in the Southeast United States, especially in Tennessee, committing typically between $100,000 and $1 million per investment, with a target total investment of $1 million to $2 million over the duration of the investment.

Harry Jacobson

Managing Partner

Past deals in Tennessee

Nusirt

Series C in 2015
NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.

Evermind

Series A in 2015
Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Preferral

Venture Round in 2014
Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.

InvisionHeart

Series A in 2014
InvisionHeart is a company focused on enhancing cardiac care through its innovative hardware and software system designed to capture and manage cardiac data. Originating from research conducted by physicians and engineers at Vanderbilt University, the technology addresses real-world clinical challenges faced by heart patients. InvisionHeart offers a mobile electrocardiograph system that allows a network of healthcare professionals, including physicians, nurses, and technicians, to securely access and annotate patient electrocardiogram tracings. The company's leadership, consisting of experienced professionals in both software and hardware development, along with a strong clinical advisory team, is dedicated to improving the care of heart patients in diverse environments.

Quire

Seed Round in 2013
Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

Diagnovus

Seed Round in 2013
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Preferral

Seed Round in 2013
Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.

VenX Medical

Seed Round in 2013
VenX Medical LLC is a medical device company based in Nashville, Tennessee, specializing in the treatment of varicose veins associated with venous insufficiency. Founded in 2009, the company develops innovative devices utilizing nanophlebectomy technology for the treatment of spider and reticular veins. Its primary offerings include VenX Reach, a minimally invasive disposable device designed for horizontal phlebectomy, and a handheld device that disrupts the vein structure to promote coagulation. These devices can be used independently or as adjuncts to other vein therapies such as endovenous ablation and sclerotherapy. Through its advanced medical technology, VenX Medical aims to provide effective solutions for patients suffering from venous disorders.

GOBA

Series A in 2013
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus

Seed Round in 2013
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Evermind

Seed Round in 2013
Evermind, Inc. offers innovative solutions that allow users to monitor their home appliances, providing reassurance for individuals living alone and their caregivers. The company's flagship product, Evermind, sends notifications via text or email when appliances such as coffee makers, TVs, and lamps are turned on or off, effectively tracking daily activities without invading privacy. This system serves as a modern check-in mechanism, enabling users to maintain their independence while ensuring that loved ones can stay informed about their well-being. Founded in 2012 and headquartered in Nashville, Tennessee, Evermind aims to replicate the supportive community dynamics of the past by utilizing technology to observe daily rituals, thereby enhancing peace of mind for both users and their families.

Diagnovus

Seed Round in 2013
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Quire

Seed Round in 2013
Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible and actionable data for population health management. The company's platform enables healthcare organizations to search, filter, and visualize patient information, taking into account social and environmental factors that influence health outcomes. By uncovering trends and patterns within patient populations, Quire supports predictive modeling, provider evaluation, and diagnostic coding. Additionally, the system helps healthcare providers identify and manage high-risk patients, strategize healthcare spending, and optimize resource allocation. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.

GOBA

Seed Round in 2013
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus

Seed Round in 2013
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Pathfinder Technologies

Seed Round in 2013
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus

Seed Round in 2012
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

Pathfinder Technologies

Venture Round in 2012
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

GOBA

Seed Round in 2012
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus

Seed Round in 2011
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.

GOBA

Seed Round in 2010
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.